HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PLAYTEX SALES GAIN 10.8% TO $122.3 MIL. IN THE THIRD QUARTER

This article was originally published in The Rose Sheet

Executive Summary

PLAYTEX SALES GAIN 10.8% TO $122.3 MIL. IN THE THIRD QUARTER (ended Sept. 24), driven by "strong" performances by its major product lines, the company said. Third quarter net earnings were $10.8 mil. compared to a net loss of $114.6 mil. in the 1993 period, when the company had a $121.6 mil. write-off of excess cost related to its acquisition of Jhirmack in the early 1980s and $29.3 mil. in interest expense. Operating earnings for the 1994 third quarter were $38 mil., compared to an operating loss of $84.9 mil. in the year-earlier period.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS001018

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel